AQR Capital Management »

Alpine Immune Sciences shares owned by AQR Capital Management

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $514k 27k 19.06

More positions owned by AQR Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Cisco Systems (CSCO)
Adobe Systems Incorporated (ADBE)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Pulte (PHM)
Cigna Corp (CI)
Humana (HUM)
CVS Caremark Corporation (CVS)

View all positions for AQR Capital Management

Top funds holding Alpine Immune Sciences

Decheng Capital
RA Capital Management
Lynx1 Capital Management
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Frazier Life Sciences Management
Cormorant Asset Management
OrbiMed Advisors
Vanguard Group
T. Rowe Price Associates
Commodore Capital
Octagon Capital Advisors
Franklin Resources
Citadel Advisors
Henderson Group

View all funds holding Alpine Immune Sciences